Cryopreservation

Based on Wikipedia: Cryopreservation

In 1967, a few hours after James Bedford succumbed to cancer, his body was placed in liquid nitrogen. It was not a medical procedure intended to treat his illness, but a desperate, speculative wager on the future of science. Bedford was the first human to be frozen with the explicit hope of future resurrection, a singular act that launched the controversial field of cryonics. He remains the only cryonics corpse from before 1974 still frozen today, a silent testament to a dream that has outlived its protagonist by nearly six decades. This moment marked a stark departure from the practical, life-saving applications of freezing that were already revolutionizing medicine. While Bedford's body waited in the cold, the rest of the scientific community was mastering the art of pausing life to save it, turning the lethal potential of ice into a tool for preserving the very essence of biology.

Cryopreservation, or cryoconservation, is the process where biological material—cells, tissues, or organs—are frozen to preserve the material for an extended period. At the heart of this technology is a simple, brutal physical reality: at sufficiently low temperatures, typically −80 °C (−112 °F) or the even more extreme −196 °C (−321 °F) achieved using liquid nitrogen, cell metabolism effectively stops. Without metabolic activity, the chemical reactions that cause cellular degradation and damage cannot proceed. It is a biological pause button. This capability has transformed how we handle biological samples, allowing for the transport of delicate materials over vast distances, the storage of samples for generations, and the creation of genetic banks that serve as insurance policies against extinction.

The potential of this technology extends far beyond human medicine. Plant materials preserved through cryopreservation can theoretically remain alive for centuries. When properly removed and regenerated, these ancient samples can grow into healthy plants, restoring genetic lineages that might otherwise be lost to time. This has proven to be an effective method for conserving plants with unique genetic makeups and, crucially, for saving species that produce recalcitrant seeds—seeds that cannot survive the drying and freezing processes traditional seed banks rely on. For these species, cryopreservation is not just a convenience; it is the only bridge between the present and the future.

However, the transition from a living, hydrated state to a frozen solid is not a gentle one. It is a journey through a minefield of physical stresses. To navigate this, scientists rely on molecules known as cryoprotective agents (CPAs). These agents are added to the biological material to reduce the osmotic shock and physical trauma cells undergo during the freezing process. Without CPAs, the formation of ice crystals would be catastrophic. Ice is sharp; it expands. When water inside a cell freezes, it forms crystals that can puncture cell membranes, tearing the cell apart from the inside out. When water outside the cell freezes, it draws water out of the cell through osmosis, causing the cell to shrivel and collapse.

Nature, in its infinite ingenuity, solved this problem long before humans ever conceived of liquid nitrogen tanks. Some of the most effective cryoprotective agents used in research today are inspired by plants and animals that have evolved unique cold tolerance to survive harsh winters. We look to trees, wood frogs, and tardigrades for the blueprint of survival. The tardigrade, a microscopic animal often called a water bear, can survive freezing by replacing most of its internal water with a sugar called trehalose. This sugar prevents the water from crystallizing, maintaining the structural integrity of the cell membranes even in the most extreme cold. Mixtures of solutes can achieve similar effects, but not all solutes are created equal. Some, including salts, have the disadvantage that they may be toxic at the intense concentrations required for freezing.

The wood frog offers perhaps the most dramatic example of freeze tolerance in vertebrates. These small amphibians can tolerate the freezing of their blood and other tissues, a feat that seems impossible for warm-blooded life. As winter approaches, the wood frog accumulates urea in its tissues in preparation for overwintering. Then, in a response to internal ice formation, the liver glycogen is converted in large quantities to glucose. Both urea and glucose act as "cryoprotectants," limiting the amount of ice that forms and reducing the osmotic shrinkage of cells. The result is a frog that can freeze solid, its heart stopped, its breathing ceased, only to thaw out in the spring and hop away.

Research into this phenomenon, known as "freezing frogs," has been performed primarily by the Canadian researcher Dr. Kenneth B. Storey. His work has revealed the limits of this survival strategy: frogs can survive many freeze-thaw events during winter, but only if no more than about 65% of the total body water freezes. If the ice exceeds this threshold, the structural damage becomes lethal. Freeze tolerance is known in a select few vertebrates: five species of frogs (Rana sylvatica, Pseudacris triseriata, Hyla crucifer, Hyla versicolor, Hyla chrysoscelis), one species of salamander (Salamandrella keyserlingii), one species of snake (Thamnophis sirtalis), and three species of turtles (Chrysemys picta, Terrapene carolina, Terrapene ornata). Snapping turtles (Chelydra serpentina) and wall lizards (Podarcis muralis) also survive nominal freezing, though it has not been established that this is an adaptive trait for overwintering in the same way it is for the frogs. In the specific case of Rana sylvatica, the cryopreservant is ordinary glucose, which increases in concentration by approximately 19 mmol/L when the frogs are cooled slowly, a precise biological adjustment that turns a death sentence into a dormant state.

The theoretical underpinnings of human cryopreservation began to take shape in the mid-20th century, driven by the curiosity of visionaries like James Lovelock. In 1953, Lovelock suggested that damage to red blood cells during freezing was due to osmotic stress. He posited that increasing the salt concentration in a dehydrating cell might damage it, a hypothesis that shifted the focus from the ice itself to the environment the cells were trapped in. By the mid-1950s, Lovelock was experimenting with the cryopreservation of rodents, determining that hamsters could be frozen with 60% of the water in the brain crystallized into ice with no adverse effects, though other organs remained susceptible to damage.

The application of these principles to human materials began in 1954, a year that marked a turning point in reproductive medicine. Three pregnancies resulted from the insemination of previously frozen sperm, proving that human gametes could survive the freeze-thaw cycle. The momentum built quickly. In 1957, a team of scientists in the UK directed by Christopher Polge successfully cryopreserved fowl sperm, opening the door for livestock preservation. Then, in 1963, Peter Mazur, working at Oak Ridge National Laboratory in the U.S., demonstrated a critical principle that would define the field for decades: lethal intracellular freezing could be avoided if cooling was slow enough to permit sufficient water to leave the cell during the progressive freezing of the extracellular fluid.

Mazur's discovery highlighted the delicate balance required in cryopreservation. The rate of cooling differs between cells of differing size and water permeability. A typical cooling rate around 1 °C per minute is appropriate for many mammalian cells after treatment with cryoprotectants such as glycerol or dimethyl sulfoxide (DMSO), but this rate is not a universal optimum. This specific rate can be achieved using devices such as rate-controlled freezers or benchtop portable freezing containers, allowing for a controlled, predictable environment for the cells.

The timeline of human cryonics is punctuated by both tragedy and technical milestones. On April 22, 1966, the first human cadaver was frozen. The body, that of an elderly woman from Los Angeles whose name remains unknown, had been embalmed for two months before being placed in liquid nitrogen and stored at just above freezing. The experiment was short-lived; she was soon thawed out and buried by her relatives, a pragmatic end to a scientific curiosity. It was James Bedford's freezing in 1967 that truly captured the public imagination, driven by the hope of resurrection rather than just storage.

The phenomena that cause damage to cells during cryopreservation mainly occur during the freezing stage itself. These include solution effects, extracellular ice formation, dehydration, and intracellular ice formation. Many of these effects can be reduced by cryoprotectants, but the process is never without risk. Once the preserved material has become frozen, it is relatively safe from further damage; the danger lies in the transition. The main techniques to prevent cryopreservation damages are a well-established combination of controlled rate and slow freezing and a newer flash-freezing process known as vitrification.

Controlled-rate and slow freezing, also known as slow programmable freezing (SPF), is a technique where cells are cooled to around -196 °C over the course of several hours. This method was developed during the early 1970s and eventually resulted in the first human frozen embryo birth in 1984. Since then, machines that freeze biological samples using programmable sequences have become standard equipment in hospitals, veterinary practices, and research laboratories around the world. These machines are used for freezing oocytes, skin, blood products, embryos, sperm, stem cells, and general tissue preservation. The impact of this technology is staggering. The number of live births from frozen embryos "slow frozen" is estimated at some 300,000 to 400,000, representing roughly 20% of the estimated 3 million in vitro fertilization (IVF) births.

The science behind slow freezing is a study in precision. Lethal intracellular freezing is avoided if cooling is slow enough to permit sufficient water to leave the cell. As the extracellular fluid freezes, the concentration of solutes outside the cell rises, drawing water out of the cell to balance the osmotic pressure. If this process is too fast, the water inside the cell freezes before it can escape, shattering the cell from within. To minimize the growth of extracellular ice crystals and recrystallization, researchers can use biomaterials such as alginates, polyvinyl alcohol, or chitosan to impede ice crystal growth alongside traditional small molecule cryoprotectants.

There is a growing body of evidence suggesting that frozen embryos stored using slow-freezing techniques may in some ways be "better" than fresh ones in IVF. Studies indicate that using frozen embryos and eggs rather than fresh ones reduced the risk of stillbirth and premature delivery, though the exact reasons for this phenomenon are still being explored. It suggests that the freezing process might select for more robust embryos or that the uterine environment is more favorable when the hormonal cycle is not synchronized with the retrieval.

Vitrification represents a different approach entirely. It is a flash-freezing, or ultra-rapid cooling, process that helps to prevent the formation of ice crystals altogether. Instead of forming crystals, the water inside and outside the cell transitions into a glass-like solid state, a process that requires high concentrations of cryoprotectants and extremely rapid cooling rates. Researchers Greg Fahy and William F. Rall helped to introduce vitrification to reproductive cryopreservation in the mid-1980s. This technique has revolutionized the preservation of oocytes, which are particularly sensitive to ice damage due to their large size and high water content.

The distinction between these two methods—slow freezing and vitrification—is not merely academic; it has profound implications for the success rates of medical procedures and the future of species conservation. Slow freezing allows for a more gradual adaptation of the cell to the changing environment, minimizing osmotic shock, but it carries the risk of ice crystal formation if the rate is not perfectly calibrated. Vitrification eliminates the risk of ice crystals but introduces the risk of toxicity from the high concentrations of cryoprotectants required to achieve the glassy state.

The journey of cryopreservation from a theoretical curiosity to a cornerstone of modern biology is a testament to human ingenuity. We have learned to mimic the wood frog, to harness the trehalose of the tardigrade, and to engineer solutions that allow life to pause and resume. From the first frozen sperm in 1954 to the millions of children born from frozen embryos today, the technology has moved from the fringe to the mainstream. Yet, the shadow of James Bedford remains. His frozen form serves as a reminder that while we have mastered the freezing of cells and tissues, the freezing of a whole human body, with the hope of bringing it back to a vibrant life, remains an unfulfilled promise.

The future of cryopreservation lies in the refinement of these techniques. As we learn more about the molecular mechanisms of freeze tolerance in nature, we can develop better CPAs that are less toxic and more effective. The integration of biomaterials to control ice crystal growth offers new avenues for preserving complex tissues and organs, a goal that remains elusive but increasingly within reach. The success of cryopreservation in agriculture and conservation highlights its potential to protect biodiversity in a changing climate. For plants that produce recalcitrant seeds, for species on the brink of extinction, cryopreservation offers a lifeline.

In the end, cryopreservation is about time. It is the act of stealing moments from the relentless march of decay, of holding life in suspension until the conditions are right for it to continue. Whether it is a wood frog waiting for the spring sun, a human embryo waiting for a mother's womb, or a James Bedford waiting for a future technology, the principle is the same: life is resilient, and with the right tools, it can be paused, preserved, and protected. The science has come a long way since the first experimental freezing of a hamster brain in the 1950s. We now know that the key to survival in the cold is not just the temperature, but the preparation, the chemistry, and the precise control of the freezing process.

The legacy of the early pioneers like Lovelock, Mazur, and Polge is written in the millions of lives saved and the species preserved. Their work laid the foundation for a world where biological material can be stored indefinitely, waiting for a future where it can be used to heal, to reproduce, and to restore. As we stand on the precipice of new breakthroughs in tissue engineering and organ preservation, the lessons learned from the wood frog and the tardigrade continue to guide us. The ice is no longer a barrier; it is a bridge.

The story of cryopreservation is far from over. With every new study on vitrification, every successful birth from a frozen embryo, and every new species added to the cryogenic bank, the boundaries of what is possible expand. The dream of James Bedford, once the subject of ridicule and skepticism, has evolved into a serious field of inquiry, driven by the same fundamental human desire that drove the early experiments: the desire to conquer time, to save what is precious, and to ensure that life, in all its fragile complexity, endures. The cold is no longer the enemy; it is the guardian of life's potential.